15 results for «154»

Filter By

15 results

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Imaging-guided left main PCI - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Imaging-guided left main PCI

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People

03 Apr 2022

Elad Asher provides his take on this phase IIb trial in healthy people ages 50 to 80 showing that the novel intravenous treatment bentracimab significantly restored platelet function in patients receiving oral P2Y12 inhibitor ticagrelor. The clinical trial was presented by Deepak L. Bhatt at the American College of Cardiology...

Elad Asher

Author

Elad Asher
Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People

STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes

19 Oct 2020

At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.

Author

Nicolas Dumonteil
Live from TCT Connect 2020: The STS/ACC TVT registry

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

EXCEL: 5-year outcomes from a randomized trial of PCI vs. CABG in patients with left main coronary artery disease

01 Oct 2019

At TCT 2019 in San Francisco - USA, Gregg W. Stone presented the results of the EXCEL trial. Read the summary and analysis provided by Luis Ortega-Paz.

Luis Ortega-Paz

Author

Luis Ortega-Paz
EXCEL: 5-year outcomes from a randomized trial of PCI vs. CABG in patients with left main coronary artery disease

egnite, Inc. Expands into Cardiovascular Disease Supported by New Data on the State of Care for Patients with Atrial Fibrillation.

17 May 2022

Supraflex Cruz RCT in high bleeding risk patients now published in Circulation

16 Oct 2024

Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients

26 Oct 2023

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020

19 Oct 2020

Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!

Vijay Kunadian

Author

Vijay Kunadian
 #TCTConnect 2020 summary and take home messages
Didn’t find what you were looking for?